Next Article in Journal / Special Issue
Intraocular Implants for the Treatment of Autoimmune Uveitis
Previous Article in Journal
The Effect of Superstructures Connected to Implants with Different Surface Properties on the Surrounding Bone
Previous Article in Special Issue
Human Keratoconus Cell Contractility is Mediated by Transforming Growth Factor-Beta Isoforms
Article Menu

Export Article

Open AccessArticle
J. Funct. Biomater. 2015, 6(3), 634-649; doi:10.3390/jfb6030634

Bioengineered Lacrimal Gland Organ Regeneration in Vivo

1
Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan
2
Laboratory of Organ Regeneration, RIKEN Center for Developmental Biology, Kobe, Hyogo 650-0047, Japan
3
Organ Technologies Inc., Chiyoda-ku, Tokyo 101-0048, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: Dimitrios Karamichos
Received: 27 June 2015 / Revised: 18 July 2015 / Accepted: 23 July 2015 / Published: 30 July 2015
(This article belongs to the Special Issue Ocular Tissue Engineering)
View Full-Text   |   Download PDF [823 KB, uploaded 30 July 2015]   |  

Abstract

The lacrimal gland plays an important role in maintaining a homeostatic environment for healthy ocular surfaces via tear secretion. Dry eye disease, which is caused by lacrimal gland dysfunction, is one of the most prevalent eye disorders and causes ocular discomfort, significant visual disturbances, and a reduced quality of life. Current therapies for dry eye disease, including artificial tear eye drops, are transient and palliative. The lacrimal gland, which consists of acini, ducts, and myoepithelial cells, develops from its organ germ via reciprocal epithelial-mesenchymal interactions during embryogenesis. Lacrimal tissue stem cells have been identified for use in regenerative therapeutic approaches aimed at restoring lacrimal gland functions. Fully functional organ replacement, such as for tooth and hair follicles, has also been developed via a novel three-dimensional stem cell manipulation, designated the Organ Germ Method, as a next-generation regenerative medicine. Recently, we successfully developed fully functional bioengineered lacrimal gland replacements after transplanting a bioengineered organ germ using this method. This study represented a significant advance in potential lacrimal gland organ replacement as a novel regenerative therapy for dry eye disease. In this review, we will summarize recent progress in lacrimal regeneration research and the development of bioengineered lacrimal gland organ replacement therapy. View Full-Text
Keywords: lacrimal glands; regenerative medicine; 3D cell manipulation; organ regeneration; dry eye disease lacrimal glands; regenerative medicine; 3D cell manipulation; organ regeneration; dry eye disease
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Hirayama, M.; Tsubota, K.; Tsuji, T. Bioengineered Lacrimal Gland Organ Regeneration in Vivo. J. Funct. Biomater. 2015, 6, 634-649.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Funct. Biomater. EISSN 2079-4983 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top